Cancer Treatment in China — Advanced Oncology for International Patients
Oncology & Advanced Treatment · International Patients
Cancer treatment in China now includes options many countries simply do not have — CyberKnife robotic radiosurgery, the world's first approved CAR-T therapy for gastric cancer, robotic surgery and weekly China–US expert case reviews — delivered at a leading Grade-A (三甲) tertiary hospital in the Guangzhou / Greater Bay Area region, with transparent all-inclusive pricing and full English support.
At a glance
- Where: a Grade-A (三甲) tertiary general hospital in the Guangzhou / Greater Bay Area region with a dedicated international medical centre.
- What: CyberKnife radiosurgery, CAR-T cell therapy (lymphoma and gastric cancer), precision radiotherapy, robotic surgery, tumour-treating fields (TTF), interventional oncology and integrative supportive care.
- How pricing works: written all-inclusive quotes before you commit — ward, meals, interpreter, report translation and airport pick-up included. See how our all-inclusive packages work →
- First step: a remote specialist review of your existing records — you get a considered second opinion before any travel decision. Start here →
Why international patients choose this hospital
Credentials you can verify, not marketing language.
- Accredited as a Grade-A tertiary (三甲) hospital since 2011 — China's highest hospital classification.
- Ranked among China's top non-public general hospitals nationally.
- A designated hospital under the Hong Kong–Macao "Medicine and Device Connect" scheme, permitted to use approved drugs and devices from Hong Kong and Macao.
- Listed among medical providers recognised by the U.S. Embassy in China and Japan's Ministry of Foreign Affairs.
- One of Guangdong's first officially designated international medical service pilot hospitals (2026).
- 20,000+ international patients received over the past three years, with a dedicated international patient department.
- Held JCI accreditation from 2018 to 2021; its oncology centre became Asia's first institutional member of the International Radiosurgery Society in 2021.
Treatment programmes
Each programme is delivered by the hospital's specialist teams; SinoCareLink coordinates records review, travel, language support and aftercare logistics.
CyberKnife robotic radiosurgery
Sixth-generation (M6) robotic radiosurgery for brain, lung, liver, pancreatic, prostate and spinal tumours — no incision, no anaesthesia, typically 1–5 outpatient-style sessions.
CyberKnife in China: cost & process →Gastric cancer CAR-T (CLDN18.2)
The world's first and only approved CAR-T therapy for gastric cancer — approved in China and currently unavailable in most countries. Clear eligibility criteria apply.
Check eligibility criteria →CAR-T for lymphoma
Commercial CD19 CAR-T therapy for relapsed / refractory large B-cell lymphoma after two or more lines of treatment, delivered at certified treatment centres.
The international patient journey →Precision radiotherapy
Next-generation Varian linear accelerator with IMRT, RapidArc, SRS and SBRT modes, guided by 256-slice dual-source CT, 3.0T MRI and PET/CT imaging.
Ask about radiotherapy →Robotic & minimally invasive surgery
Da Vinci robotic programmes for prostate and breast cancer, laparoscopic GI cancer surgery, and orthopaedic robot-assisted procedures with imported implants.
Joint replacement programme →Tumour-treating fields (TTF)
Wearable electric-field therapy for recurrent glioblastoma, used alongside standard care under specialist supervision.
Enquire →Interventional & supportive oncology
TACE, ablation, deep hyperthermia, thermal perfusion, pain management, oncology nursing and integrated Traditional Chinese Medicine support.
Enquire →Early screening & diagnosis
PET/CT (≈US$1,000), tumour markers, genetic testing and endoscopy — often the sensible first step before any treatment decision.
Cancer screening in China →Weekly China–US multidisciplinary case review
Every week, the hospital's oncology centre holds a scheduled China–US multicentre multidisciplinary tumour board (MDT): radiotherapy, medical oncology, surgery, imaging, pathology and rehabilitation specialists from China and the United States review cases together — diagnosis, staging and a written comprehensive treatment plan. Several of the centre's senior physicians and physicists trained or practised at major US institutions.
For international patients this matters in a practical way: your case can be reviewed against both Chinese and Western standards of care before you travel. That is exactly what our remote second opinion service arranges.
Transparent pricing anchors
Indicative all-inclusive package levels, converted from partner-hospital RMB rate cards (≈6.35 RMB/USD). Every patient receives a written quote before paying anything.
| Programme | Indicative all-inclusive level | Typical inpatient stay |
|---|---|---|
| CyberKnife radiosurgery (3–5 sessions) | ≈ US$14,000–17,500 | 8–10 nights |
| CAR-T therapy (lymphoma, incl. commercial cell product) | ≈ US$205,000–210,000 | ~25 nights |
| Da Vinci robotic cancer surgery (prostate / breast) | ≈ US$30,000–32,000 | 10–21 nights |
| Knee / hip replacement (imported implant options) | ≈ US$15,000–19,000 | ~10 nights |
| PET/CT scan | ≈ US$1,000 | same-visit imaging |
Package levels include standard ward, meals (halal options available), a companion bed, medical interpreting, translated discharge reports and airport / high-speed-rail pick-up. Surgical quotes are given as a band, not a bare headline price — here is exactly what "all-inclusive" covers. Figures are indicative, not an offer; complex cases are priced after specialist review.
How it works for international patients
- Send your records. Reports, imaging and treatment history — we handle medical translation. Start with a specialist case review.
- Receive a written opinion and plan. Suitability, treatment options, realistic timelines and an all-inclusive price band — reviewed through the hospital's MDT process where appropriate.
- Travel arrangements. Many short programmes fit China's 30-day visa-free entry (50 countries) or 240-hour visa-free transit; for longer treatment programmes the hospital can issue a visa invitation letter to support your application.
- Treatment with full support. Airport pick-up, interpreter at every consultation, a named coordinator, halal meals on request, companion accommodation.
- Go home with a complete record. Translated discharge summary, imaging and follow-up plan your home oncologist can act on.
Who this programme is for
Two groups get the most value from coming to China for cancer care:
- Patients who want certainty before committing — a structured second opinion on diagnosis and treatment options, at specialist level, without waiting months.
- Patients whose home system has run out of options — where a therapy (such as gastric cancer CAR-T) is not approved locally, waiting lists are long, or self-pay prices are far beyond reach.
We are deliberately honest about the opposite case too: if your home country already offers the same treatment on reasonable terms, we will say so in the written opinion.
Frequently asked questions
Can I really access treatments in China that aren't available at home?
Yes, in specific cases. The clearest example is CAR-T for gastric cancer (CLDN18.2-targeted), approved in China and currently unavailable in most other countries. Others — such as CyberKnife — exist elsewhere but often with long waits or high self-pay prices.
Will language be a problem?
No. A medical interpreter accompanies consultations, treatment consent is explained in English, and your discharge documentation is professionally translated.
How do I know the price won't change once I arrive?
You receive a written all-inclusive quote (a defined band for surgery) before you travel. Any change of clinical plan is explained and re-quoted in writing before it happens. Details here.
Is this a hospital I can trust?
The partner hospital is a Grade-A tertiary (三甲) institution, held JCI accreditation 2018–2021, participates in official international medical pilot programmes, and has received 20,000+ international patients in three years. We name it, with full documentation, in your written quote.
What if my cancer can't be treated there?
Then we tell you. The case review exists to filter, not to sell — where another centre in our network (or staying home) is the better answer, that is what the written opinion will say.
Start with your records, not a plane ticket. Send your reports for a specialist case review — you'll get a written opinion and an all-inclusive price band before you decide anything.